Oncolytics Biotech (ONCY) Earnings Analysis
Oncolytics Biotech (ONCY) next reports earnings on 2026-08-14, consensus EPS -0.07 USD. Last quarter (2026-05-14) it missed with EPS -0.08 USD vs -0.05 USD est (-60%). It has beaten estimates in 4/6 recent quarters (67%). Trailing P/E -3.46.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ONCY next report earnings?
| Next earnings date | 2026-08-14 |
|---|---|
| Consensus EPS estimate | -0.07 USD |
| Revenue estimate | n/a |
ONCY earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-14 | -0.08 USD | -0.05 USD | -60% | Miss |
| 2026-03-30 | -0.08 USD | -0.06 USD | -33.3% | Miss |
| 2025-11-12 | -0.1 USD | -0.12 USD | +16.7% | Beat |
| 2025-08-08 | -0.05 USD | -0.11 USD | +54.5% | Beat |
| 2025-03-07 | -0.07 USD | -0.08 USD | +12.5% | Beat |
| 2024-08-01 | -0.07 USD | -0.08 USD | +12.5% | Beat |
Beat rate: 4/6 (67%) over reported quarters with consensus data.
ONCY valuation and analyst view
| Trailing P/E | -3.46 |
|---|---|
| Trailing EPS | -0.31634 USD |
| Price / book | -25.51 |
| Dividend yield | 0.00% |
| Market cap | 0.08B |
| Analyst consensus | Buy (8 buy / 2 hold / 0 sell) |
Related research pages
Frequently asked questions
When is Oncolytics Biotech (ONCY)'s next earnings date?
Oncolytics Biotech is next scheduled to report on 2026-08-14, with a consensus EPS estimate of -0.07 USD.
Did ONCY beat earnings last quarter?
In its 2026-05-14 report, ONCY posted EPS of -0.08 USD versus a -0.05 USD estimate — a miss of 60%.
What is ONCY's earnings track record?
Over the last 6 reported quarters with consensus data, ONCY beat estimates 4 times (67%).
What is ONCY's current P/E ratio and EPS?
ONCY trades at a trailing P/E of -3.46 on trailing EPS of -0.31634155450290263 USD.
What do analysts rate ONCY?
Analyst consensus is "Buy" across 10 ratings (0 strong buy, 8 buy, 2 hold, 0 sell, 0 strong sell).